BioPharma Credit launches $300m London IPO

Aidan Gregory

March 01, 2017 06:00 pm

LinkedIn
X
Show more sharing options

File photo dated 25/08/15 of a sign outside the London Stock Exchange Group in the City of London. The London Stock Exchange has said its £21 billion merger with Germany's Deutsche Borse is likely to be blocked by the European Commission. | Philip Toscano/PA Wire/PA Images

BioPharma Credit, the closed end investment company focused on life sciences, has announced the largest UK IPO of the year so far.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login

✔ 4,000 annual insights
✔ 700+ notes and long-form analyses
✔ 4 capital markets databases
✔ Daily newsletters across markets and asset classes
✔ 2 weekly podcasts

BioPharma Credit launches $300m London IPO

BioPharma Credit, the closed end investment company focused on life sciences, has announced the largest UK IPO of the year so far.

Unlock this article.

Topics

Most recent